These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 26055036)

  • 1. [Inability to walk in a 41-year-old man].
    Karaa-Zbidi N; Damade R; Lhote F
    Rev Med Interne; 2016 Jan; 37(1):62-5. PubMed ID: 26055036
    [No Abstract]   [Full Text] [Related]  

  • 2. Osteomalacia induced by a phosphaturic mesenchymal tumor secreting fibroblast growth factor 23.
    Nagae K; Uchi H; Ito T; Moroi Y; Oda Y; Furue M
    Eur J Dermatol; 2015 Apr; 25(2):199-200. PubMed ID: 25788099
    [No Abstract]   [Full Text] [Related]  

  • 3. [Osteomalacia due to phosphate deficiency caused by a tumor. Focus on FGF23 in physiology and clinic].
    Westerberg PA; Linde T; Ljunggren O
    Lakartidningen; 2012 Aug 8-21; 109(32-33):1414-6. PubMed ID: 22953430
    [No Abstract]   [Full Text] [Related]  

  • 4. Elevated FGF23 in a patient with hypophosphatemic osteomalacia associated with neurofibromatosis type 1.
    Sahoo SK; Kushwaha P; Bharti N; Khedgikar V; Trivedi R; Agrawal V; Ahmad N; Zaidi G; Pal L; Ito N; Bhatia E
    Bone; 2019 Dec; 129():115055. PubMed ID: 31476437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenous osteomalacia.
    Ghosh S; Sinha R; Bandyopadhyay R; Malhotra M
    J Cancer Res Ther; 2009; 5(3):210-2. PubMed ID: 19841566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Case of Hypophosphatemia due to Oncogenic Osteomalacia in a Patient with Natural Killer T-Cell Lymphoma.
    Zheng G; Kanduri SR; Canterbury JP; Nguyen T; Velez JCQ
    Kidney Blood Press Res; 2021; 46(5):647-651. PubMed ID: 34293749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature.
    Mori Y; Ogasawara T; Motoi T; Shimizu Y; Chikazu D; Tamura K; Fukumoto S; Takato T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e57-63. PubMed ID: 20219587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
    Jonsson KB; Zahradnik R; Larsson T; White KE; Sugimoto T; Imanishi Y; Yamamoto T; Hampson G; Koshiyama H; Ljunggren O; Oba K; Yang IM; Miyauchi A; Econs MJ; Lavigne J; Jüppner H
    N Engl J Med; 2003 Apr; 348(17):1656-63. PubMed ID: 12711740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thoracic phosphaturic mesenchymal tumors causing oncogenic osteomalacia.
    Puthenveetil PJ; Hattab EM; Peacock M; Horn EM
    J Clin Neurosci; 2013 Aug; 20(8):1057-61. PubMed ID: 23618679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of systemic venous sampling of FGF23 for identifying tumours responsible for tumour-induced osteomalacia.
    Ito N; Shimizu Y; Suzuki H; Saito T; Okamoto T; Hori M; Akahane M; Fukumoto S; Fujita T
    J Intern Med; 2010 Oct; 268(4):390-4. PubMed ID: 20698924
    [No Abstract]   [Full Text] [Related]  

  • 11. Oncogenic osteomalacia: two case reports with surprisingly different outcomes.
    Seijas R; Ares O; Sierra J; Pérez-Dominguez M
    Arch Orthop Trauma Surg; 2009 Apr; 129(4):533-9. PubMed ID: 19125258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypophosphatemia related to paraneoplastic Cushing syndrome in prostate cancer: cure after bilateral adrenalectomy.
    Ramon I; Kleynen P; Valsamis J; Body JJ; Karmali R
    Calcif Tissue Int; 2011 Dec; 89(6):442-5. PubMed ID: 21910004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cutaneous tumors and osteomalacia].
    Caille A; Duterque M
    Ann Dermatol Venereol; 1996; 123(12):848-51. PubMed ID: 9636780
    [No Abstract]   [Full Text] [Related]  

  • 14. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
    Fukumoto S; Yamashita T
    N Engl J Med; 2003 Jul; 349(5):505-6; author reply 505-6. PubMed ID: 12892105
    [No Abstract]   [Full Text] [Related]  

  • 15. A Dancer with Fractures: What Lies Beneath?
    Habbsa S; Canakis A; George L; Thomas A; Hu Y; Cross RK; Whitlatch HB
    Dig Dis Sci; 2023 Jan; 68(1):54-57. PubMed ID: 36156755
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
    Kida Y
    N Engl J Med; 2003 Jul; 349(5):505-6; author reply 505-6. PubMed ID: 12890852
    [No Abstract]   [Full Text] [Related]  

  • 17. Oncogenic osteomalacia--a complex dance of factors.
    Carpenter TO
    N Engl J Med; 2003 Apr; 348(17):1705-8. PubMed ID: 12711747
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hypophosphatemia and tumor-induced osteomalacia].
    van der Rest C; Cavalier E; Colson L; Kaux JF; Krzesinski JM; Reginster JY; Hustinx R; Delanaye P
    Rev Med Suisse; 2011 Aug; 7(306):1630-3. PubMed ID: 21972729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor induced osteomalacia: a forgotten paraneoplastic syndrome?
    Zadik Y; Nitzan DW
    Oral Oncol; 2012 Feb; 48(2):e9-10. PubMed ID: 21985764
    [No Abstract]   [Full Text] [Related]  

  • 20. Idiopathic hypophosphatemic osteomalacia: recurrent pseudofracture of the proximal femur in a 65-year-old man.
    Chen YX; Gao YS
    Endocrine; 2017 Feb; 55(2):651-652. PubMed ID: 27995499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.